352 related articles for article (PubMed ID: 22465831)
21. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
22. Metformin use and endometrial cancer survival.
Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
[TBL] [Abstract][Full Text] [Related]
23. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
24. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
25. No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study.
Frouws MA; Sibinga Mulder BG; Bastiaannet E; Zanders MMJ; van Herk-Sukel MPP; de Leede EM; Bonsing BA; Mieog JSD; Van de Velde CJH; Liefers GJ
Medicine (Baltimore); 2017 Mar; 96(10):e6229. PubMed ID: 28272215
[TBL] [Abstract][Full Text] [Related]
26. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
[TBL] [Abstract][Full Text] [Related]
27. Metformin intake is associated with better survival in ovarian cancer: a case-control study.
Kumar S; Meuter A; Thapa P; Langstraat C; Giri S; Chien J; Rattan R; Cliby W; Shridhar V
Cancer; 2013 Feb; 119(3):555-62. PubMed ID: 23208739
[TBL] [Abstract][Full Text] [Related]
28. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
He XX; Tu SM; Lee MH; Yeung SJ
Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
[TBL] [Abstract][Full Text] [Related]
29. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract][Full Text] [Related]
30. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
[TBL] [Abstract][Full Text] [Related]
31. Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.
Nayan M; Finelli A; Jewett MA; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Clin Genitourin Cancer; 2017 Apr; 15(2):300-305. PubMed ID: 27424258
[TBL] [Abstract][Full Text] [Related]
32. Antidiabetic therapies affect risk of pancreatic cancer.
Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
[TBL] [Abstract][Full Text] [Related]
33. Do endometrial cancer patients benefit from metformin intake?
Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
[TBL] [Abstract][Full Text] [Related]
34. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
35. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
36. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
37. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
38. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
Kim HJ; Kwon H; Lee JW; Kim HJ; Lee SB; Park HS; Sohn G; Lee Y; Koh BS; Yu JH; Son BH; Ahn SH
Breast Cancer Res; 2015 May; 17(1):64. PubMed ID: 25935404
[TBL] [Abstract][Full Text] [Related]
39. Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32824907
[TBL] [Abstract][Full Text] [Related]
40. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
